Literature DB >> 9662381

Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adults.

R E Walker1, C S Carter, L Muul, V Natarajan, B R Herpin, S F Leitman, H G Klein, C A Mullen, J A Metcalf, M Baseler, J Falloon, R T Davey, J A Kovacs, M A Polis, H Masur, R M Blaese, H C Lane.   

Abstract

The CD4+ T-cell pool in HIV-infected patients is in a constant state of flux as CD4+ T cells are infected and destroyed by HIV and new cells take their place. To study T-cell survival, we adoptively transferred peripheral blood lymphocytes transduced with the neomycin phosphotransferase gene between syngeneic twin pairs discordant for HIV infection. A stable fraction of marked CD4+ T cells persisted in the circulation for four to eighteen weeks after transfer in all patients. After this time there was a precipitous decline in marked cells in three of the patients. At approximately six months, marked cells were in lymphoid tissues in proportions comparable to those found in peripheral blood. In two patients, the proportion of total signal for the transgene (found by PCR analysis) in the CD4/CD45RA+ T-cell population relative to the CD4/CD45RO+ population increased in the weeks after cell infusion. These findings indicate that genetically-marked CD4+ T cells persist in vivo for weeks to months and that the CD4+ T-cell pool in adults is maintained mostly by the division of mature T cells rather than by differentiation of prethymic stem cells. Thus, after elements of the T-cell repertoire are lost through HIV infection, they may be difficult to replace.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9662381     DOI: 10.1038/nm0798-852

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  24 in total

1.  Nonmyeloablative immunosuppressive regimen prolongs In vivo persistence of gene-modified autologous T cells in a nonhuman primate model.

Authors:  C Berger; M L Huang; M Gough; P D Greenberg; S R Riddell; H P Kiem
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

Review 2.  Immune reconstitution in HIV-1 infected subjects treated with potent antiretroviral therapy.

Authors:  G R Kaufmann; J Zaunders; D A Cooper
Journal:  Sex Transm Infect       Date:  1999-08       Impact factor: 3.519

3.  Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection.

Authors:  B F Haynes; L P Hale; K J Weinhold; D D Patel; H X Liao; P B Bressler; D M Jones; J F Demarest; K Gebhard-Mitchell; A T Haase; J A Bartlett
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

Review 4.  Gene-marking studies of hematopoietic cells.

Authors:  C M Bollard; H E Heslop; M K Brenner
Journal:  Int J Hematol       Date:  2001-01       Impact factor: 2.490

5.  The role of mutation accumulation in HIV progression.

Authors:  Alison P Galvani
Journal:  Proc Biol Sci       Date:  2005-09-07       Impact factor: 5.349

6.  Expression of herpes simplex virus ICP47 and human cytomegalovirus US11 prevents recognition of transgene products by CD8(+) cytotoxic T lymphocytes.

Authors:  C Berger; S Xuereb; D C Johnson; K S Watanabe; H P Kiem; P D Greenberg; S R Riddell
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

7.  Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection.

Authors:  L A Chakrabarti; S R Lewin; L Zhang; A Gettie; A Luckay; L N Martin; E Skulsky; D D Ho; C Cheng-Mayer; P A Marx
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

8.  Cytokine analysis at the single cell level and lymphoproliferative responses to mycobacterial antigens in HIV-1 patients with successful virologic response to potent antiretrovirals.

Authors:  C Amiel; J P Kusnierz; Y Mouton; G Rook; J Stanford; M Singh; A Capron; G M Bahr
Journal:  J Clin Immunol       Date:  2000-11       Impact factor: 8.317

9.  CD4+ T cells from CD4C/HIVNef transgenic mice show enhanced activation in vivo with impaired proliferation in vitro but are dispensable for the development of a severe AIDS-like organ disease.

Authors:  Xiaoduan Weng; Elena Priceputu; Pavel Chrobak; Johanne Poudrier; Denis G Kay; Zaher Hanna; Tak W Mak; Paul Jolicoeur
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

Review 10.  A translational bridge to cancer immunotherapy: exploiting costimulation and target antigens for active and passive T cell immunotherapy.

Authors:  Robert H Vonderheide; Carl H June
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.